GLP-1 Reta

Price range: $185.95 through $284.95

Retatrutide is a multi-receptor tri-agonist research peptide targeting GLP-1R, GIPR, and the glucagon receptor, widely studied in metabolic and endocrine signaling research models.

Categories

Retatrutide – Multi-Receptor Tri-Agonist (GLP-1R / GIPR / GlucagonR)

Compound Name: Retatrutide
Classification: Research Peptide – Incretin-Related, Tri-Agonist

Description:

Retatrutide is a synthetic research peptide functioning as a triple agonist at the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR). This multi-pathway receptor activity has made Retatrutide a widely studied compound in metabolic, endocrine, and peptide-regulated biological research models. Its broad receptor engagement profile makes it particularly relevant in controlled studies exploring complex metabolic signaling networks.

COA Downloads:

Retatrutide 10mg COA

Disclaimer:

For Laboratory Research Use Only (RUO).
Not for human consumption. Not for therapeutic, diagnostic, or veterinary use.

Additional information

Size

10 mg, 20 mg, 24mg